Investigational treatment provides hope for some chronic liver disease sufferers

19-Apr-2016 - A new study provides hope for a new treatment in patients with primary sclerosing cholangitis, a rare condition characterised by inflammation and scarring in the bile ducts of the liver and for which there are currently no medicines. The study, presented at The International Liver Congress™ 2016 ...

Treatment for chronic hepatitis B linked to increased rates of colorectal and cervical cancer

18-Apr-2016 - A new study presented today demonstrates a potential link between treatment of long-term oral nucleos(t)ide analogues and an increased risk of colorectal (p=0.029) and cervical (p=0.049) cancer in patients with chronic Hepatitis B virus (HBV). The study results were presented at The International ...

Increase in coffee consumption could provide protective effect in non-alcoholic fatty liver disease

A daily dose of coffee could improve several key markers of NAFDL by reducing gut permeability

14-Apr-2016 - Adding coffee to the diet of people with non-alcoholic fatty liver disease (NAFLD) could help reverse the condition, according to a new study conducted in mice presented at The International Liver CongressTM 2016 in Barcelona, Spain. The study found that a daily dose of coffee (equivalent to six ...

Combined HIV and hepatitis C virus vaccination a possibility

14-Apr-2016 - A combined vaccination against Hepatitis C virus (HCV) and HIV moved a step closer, with the results of a study* presented at The International Liver Congress™ 2016 in Barcelona, Spain today. An estimated 2.3 million people globally are co-infected with HIV and HCV.1 HCV is the leading cause of ...